Can Tribulus Terrestris Protect Against Chemotherapy's Harsh Effects?
"Exploring a natural supplement for minimizing cisplatin-induced damage"
Chemotherapy, while life-saving, often brings a host of unwelcome side effects. Cisplatin, a widely used chemotherapy drug, is known for its effectiveness in treating various cancers, including lung, ovarian, head, neck, and gastric cancers. However, its potent action isn't without consequences. The drug's toxicity can impact healthy tissues, leading researchers to explore ways to mitigate these harmful effects.
One promising avenue involves the use of herbal remedies and their active compounds. These natural sources have long been recognized for their medicinal properties, offering potential protection against the toxic effects of various treatments. Among these, Tribulus terrestris (TT), a plant with a rich history in traditional medicine, has garnered attention for its potential protective qualities.
A recent study has investigated the protective effects of Tribulus terrestris extract against cisplatin-induced damage, specifically focusing on germ cell apoptosis (programmed cell death) in male mice. This research delves into how TT might counteract the harmful impact of cisplatin on these vital cells, offering a potential strategy to reduce the severity of chemotherapy's side effects.
Current Evidence and Safety
Memorial Sloan Kettering advises people to tell healthcare providers about dietary supplements, including herbs, vitamins, minerals, and natural or home remedies. Research on Tribulus terrestris has examined its effects in liver and breast cancer contexts, including studies of extract-related activity. A 2022 study specifically investigated the cytotoxic effects of T. terrestris extracts on MCF7 breast cancer and A549 lung cancer cell lines using flow cytometry, with GC–MS used to identify phytochemical constituents.
Traditional Foundations
Tribulus terrestris was extensively used in Indian and Chinese indigenous medical systems, particularly the entire plant and its fruits. The plant was documented in Shen-Nong-Ben-Cao-Jing and was used in ancient China for purposes that included treating breast cancer. A 2022 medico-historical review examined Tribulus terrestris within the context of traditional Indian medicine, while later research identified pharmacological properties of the plant.
How Tribulus Terrestris Could Shield Against Cisplatin's Toxicity
The study, published in the International Journal of Morphology, explored whether Tribulus terrestris (TT) could protect against cisplatin-induced cytotoxicity in the germ cells of male mice. The researchers administered cisplatin, a common chemotherapy drug, to a group of mice and then introduced different concentrations of TT to see if it could mitigate the harmful effects.
- p53: A tumor suppressor gene that activates in response to DNA damage.
- Bax: A pro-apoptotic protein that promotes cell death.
- Bcl-2: An anti-apoptotic protein that inhibits cell death.
Emerging Research
Recent reviews describe Tribulus terrestris as a traditional medicinal plant receiving increasing attention for potential applications in skin disease. The 2025 Frontiers in Pharmacology review highlights bioactive metabolites including steroidal saponins, flavonoids, and alkaloids. Another comprehensive review synthesizes traditional uses, phytochemical constituents, and pharmacological findings from in vitro, in vivo, and clinical research, but the available material does not establish that these findings prove protection against chemotherapy toxicity.
Evidence Gaps and Safety Questions
The listed material does not provide clinical evidence that Tribulus terrestris prevents or reduces chemotherapy side effects. One source instead identifies a patent herbal drug called Yi-Shen-Hua-Shi granule and reports effects involving chronic glomerulonephritis and TGFβ signaling in rats, which is not direct evidence about Tribulus terrestris or chemotherapy. Another source describes a scientific review evaluating the purported benefits and side effects of Tribulus terrestris supplements, underscoring that safety and effectiveness claims require careful assessment.
Preclinical and Human Evidence
Preclinical research has evaluated the cytotoxic potential of Tribulus terrestris leaf and seed extracts using the MTT assay. By contrast, a PubMed search result reports a randomized study in which 67 women with hypoactive sexual desire disorder received either 7.5 mg/day of Tribulus terrestris extract or placebo for 4 weeks. These findings represent different research contexts and do not directly demonstrate protection from cisplatin or other chemotherapy toxicities. Market comparisons also emphasize differences in disclosed dose, standardization, format, count, price, and the gap between marketing claims and human performance evidence.
A Promising Natural Ally?
While these findings are encouraging, it's important to remember that this study was conducted on mice. More research is needed to determine whether Tribulus terrestris has the same protective effects in humans undergoing chemotherapy. However, the results suggest that TT could potentially be a valuable addition to conventional cancer treatments, helping to reduce the severity of side effects and improve the quality of life for patients.
Future Directions
Market outlook sources describe future growth opportunities for Tribulus terrestris supplements driven by changing consumer needs and technological advances. One forecast projects the global Tribulus Terrestris supplement market will reach USD 1.2 billion by 2033, with a 7.5% compound annual growth rate from 2025 to 2033. Reported future directions include plant-based formulations, products targeting energy and vitality, functional foods, herbal teas, and cosmeceuticals, alongside clinical validation and consumer education.